Roles of oxidative stress and Akt signaling in doxorubicin cardiotoxicity

Biochemical and Biophysical Research Communications

Volumn 359, Issue 1, 2007, Pages 27-33

  Ichihara, Sahoko ^a,b   Yamada, Yoshiji ^a   Kawai, Yoshichika ^c,d   Osawa, Toshihiko ^c   Furuhashi, Koichi ^b   Duan, Zhiwen ^b,e   Ichihara, Gaku ^b  

^a MIE UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

^e SHENYANG MEDICAL COLLEGE   (China)

Author keywords

Angiogenesis; Apoptosis; Doxorubicin; Fenofibrate; Heart failure; Oxidative stress; Superoxide dismutase

Indexed keywords

DOXORUBICIN; FENOFIBRATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PROTEIN KINASE B; SUPEROXIDE DISMUTASE MACROGOL;

ANIMAL EXPERIMENT; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVATION; GENE EXPRESSION; HEART DISEASE; HEART LEFT VENTRICLE; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TREATMENT DURATION;

ANIMALS; ANTILIPEMIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG COMBINATIONS; MALE; MICE; MICE, INBRED C57BL; ONCOGENE PROTEIN V-AKT; OXIDATIVE STRESS; PROCETOFEN; VENTRICULAR DYSFUNCTION, LEFT;

MUS;

EID: 34249649617     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.027     Document Type: Article

References (31)

1. Blum R.H., and Carter S.K. Adriamycin. A new anticancer drug with significant clinical activity. Ann. Intern. Med. 80 (1974) 249-259
2. Von Hoff D.D., Layard M.W., Basa P., Davis Jr. H.L., Von Hoff A.L., Rozencweig M., and Muggia F.M. Risk factors for doxorubicin-induced congestive heart failure. Ann. Intern. Med. 91 (1979) 710-717
3. Keizer H.G., Pinedo H.M., Schuurhuis G.J., and Joenje H. Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol. Ther. 47 (1990) 219-231
4. Rajagopalan S., Politi P.M., Sinha B.K., and Myers C.E. Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. Cancer Res. 48 (1988) 4766-4769
5. Kim D.H., Landry III A.B., Lee Y.S., and Katz A.M. Doxorubicin-induced calcium release from cardiac sarcoplasmic reticulum vesicles. J. Mol. Cell. Cardiol. 21 (1989) 433-436
6. Arola O.J., Saraste A., Pulkki K., Kallajoki M., Parvinen M., and Voipio-Pulkki L.M. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res. 60 (2000) 1789-1792
7. Jeyaseelan R., Poizat C., Baker R.K., Abdishoo S., Isterabadi L.B., Lyons G.E., and Kedes L. A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes. J. Biol. Chem. 272 (1997) 22800-22808
8. Doroshow J.H., Locker G.Y., Ifrim I., and Myers C.E. Prevention of doxorubicin cardiac toxicity in the mouse by n-acetylcysteine. J. Clin. Invest. 68 (1981) 1053-1064
9. Siveski-Iliskovic N., Hill M., Chow D.A., and Singal P.K. Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation 91 (1995) 10-15
10. Yen H.-C., Oberley T.D., Vichitbandha S., Ho Y.-S., and St. Clair D.K. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J. Clin. Invest. 98 (1996) 1253-1260
11. Kang Y.J., Chen Y., and Epstein P.N. Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J. Biol. Chem. 271 (1996) 12610-12616
12. Diep Q.N., Benkirane K., Amiri F., Cohn J.S., Endemann D., and Schiffrin E.L. PPARα activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats. J. Mol. Cell. Cardiol. 36 (2004) 295-304
13. Ichihara S., Obata K., Yamada Y., Nagata K., Noda A., Ichihara G., Yamada A., Kato T., Izawa H., Murohara T., and Yokota M. Attenuation of cardiac dysfunction by a PPAR-α agonist is associated with down-regulation of redox-regulated transcription factors. J. Mol. Cell. Cardiol. 41 (2006) 318-329
14. Veronese F.M., Caliceti P., Schiavon O., and Sergi M. Polyethylene glycol-superoxide dismutase a conjugate in search of exploitation. Adv. Drug Deliv. Rev. 54 (2002) 587-606
15. Tamura Y., Chi L.G., Driscoll Jr. E.M., Hoff P.T., Freeman B.A., Gallagher K.P., and Lucchesi B.R. Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart. Circ. Res. 63 (1988) 944-959
16. Yamakawa T., Kadowaki Y., Garcia-Alves M., Yokoyama M., Iwashita Y., and Nishi K. Effects of polyoxyethylene-modified superoxide dismutase on reperfusion induced arrhythmia in isolated rat and guinea-pig hearts. J. Mol. Cell. Cardiol. 21 (1989) 441-452
17. Ichihara S., Senbonmatsu T., Price Jr. E., Ichiki T., Gaffney F.A., and Inagami T. Targeted deletion of angiotensin II type 2 receptor caused cardiac rupture after acute myocardial infarction. Circulation 106 (2002) 2244-2249
18. ε-(hexanonyl)lysine in protein exposed to lipid hydroperoxide. J. Biol. Chem. 274 (1999) 20406-20414
19. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106 (1980) 207-212
20. Weinstein D.M., Mihm M.J., and Bauer J.A. Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. J. Pharmacol. Exp. Ther. 294 (2000) 396-401
21. Kakinuma Y., Miyauchi T., Yuki K., Murakoshi N., Goto K., and Yamaguchi I. Novel molecular mechanism of increased myocardial endothelin-1 expression in the failing heart involving the transcriptional factor hypoxia-inducible factor-1α induced for impaired myocardial energy metabolism. Circulation 103 (2001) 2387-2394
22. Kim C.-H., Cho Y.-S., Chun Y.-S., Park J.-W., and Kim M.-S. Early expression of myocardial HIF-1α in response to mechanical stress: regulation by stretch-activated channels and the phosphatidylinostitol 3-kinase signaling pathway. Circ. Res. 90 (2002) e25-e33
23. Lee P.J., Jiang B.H., Chin B.Y., Iyer N.V., Alam J., Semenza G.L., and Choi A.M. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J. Biol. Chem. 272 (1997) 5375-5381
24. Huang Y., Hickey R.P., Yeh J.L., Liu D., Dadak A., Young L.H., Johnson R.S., and Giordano F.J. Cardiac myocyte-specific HIF-1α deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart. FASEB J. 18 (2004) 1138-1140
25. Deres P., Halmosi R., Toth A., Kovacs K., Palfi A., Habon T., Czopf L., Kalai T., Hideg K., Sumegi B., and Toth K. Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound. J. Cardiovasc. Pharmacol. 45 (2005) 36-43
26. del Peso L., Gonzalez-Garcia M., Page C., Herrera R., and Nunez G. Interleulin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278 (1997) 687-689
27. Pagé E.L., Robitaille G.A., Pouysségur J., and Richard D.E. Induction of hypoxia-inducible factor-1α by transcriptional and translational mechanisms. J. Biol. Chem. 277 (2002) 48403-48409
28. Taniyama Y., and Walsh K. Elevated myocardial Akt signaling ameliorates doxorubicin-induced congestive heart failure and promotes heart growth. J. Mol. Cell. Cardiol. 34 (2002) 1241-1247
29. Ishida M., Tomita S., Nakatani T., Fukuhara S., Hamamoto M., Nagaya N., Ohtsu Y., Suga M., Chikao Y., Yagihara T., Yamada K., and Kitamura S. Bone marrow mononuclear cell transplantation had beneficial effects on doxorubicin-induced cardiomyopathy. J. Heart Lung Transplant. 23 (2004) 436-445
30. Chen S., Garami M., and Gardner D.G. Doxorubicin selectively inhibits brain versus arterial natriuretic peptide gene expression in cultured neonatal rat myocytes. Hypertension 34 (1999) 1223-1231
31. Gewirtz D.A. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 57 (1999) 727-741